Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021

SELL
$13.16 - $22.47 $140,101 - $239,215
-10,646 Closed
0 $0
Q2 2021

Jul 22, 2021

BUY
$19.57 - $26.32 $197,657 - $265,832
10,100 Added 1849.82%
10,646 $234,000
Q1 2021

Apr 12, 2021

SELL
$17.58 - $32.59 $7,981 - $14,795
-454 Reduced 45.4%
546 $13,000
Q4 2020

Feb 11, 2021

BUY
$10.99 - $20.4 $10,990 - $20,400
1,000 New
1,000 $18,000

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.